183 related articles for article (PubMed ID: 26531698)
21. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
22. The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population.
Wang JJ; Jiang LQ; He B; Shi KL; Li JW; Zou LP
Int J Immunogenet; 2009 Apr; 36(2):113-8. PubMed ID: 19284445
[TBL] [Abstract][Full Text] [Related]
23. CD80 and CD86 IgC domains are important for quaternary structure, receptor binding and co-signaling function.
Girard T; Gaucher D; El-Far M; Breton G; Sékaly RP
Immunol Lett; 2014 Sep; 161(1):65-75. PubMed ID: 24845157
[TBL] [Abstract][Full Text] [Related]
24. Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
Karabon L; Tupikowski K; Tomkiewicz A; Partyka A; Pawlak-Adamska E; Wojciechowski A; Kolodziej A; Dembowski J; Zdrojowy R; Frydecka I
Pathol Oncol Res; 2017 Oct; 23(4):837-843. PubMed ID: 28101800
[TBL] [Abstract][Full Text] [Related]
25. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function.
Kariv I; Truneh A; Sweet RW
J Immunol; 1996 Jul; 157(1):29-38. PubMed ID: 8683128
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.
Matsui T; Kurokawa M; Kobata T; Oki S; Azuma M; Tohma S; Inoue T; Yamamoto K; Nishioka K; Kato T
J Immunol; 1999 Apr; 162(7):4328-35. PubMed ID: 10201965
[TBL] [Abstract][Full Text] [Related]
28. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?
Kristiansen OP; Larsen ZM; Pociot F
Genes Immun; 2000 Feb; 1(3):170-84. PubMed ID: 11196709
[TBL] [Abstract][Full Text] [Related]
29. Investigation of CTLA-4 and CD28 gene polymorphisms in patients with diabetes mellitus type 2 using PCR-RFLP in a Turkish population.
Uzer E; Dilmec F; Akkafa F; Boduroglu O; van Kuilenburg AB
West Indian Med J; 2010 Jun; 59(3):235-40. PubMed ID: 21291098
[TBL] [Abstract][Full Text] [Related]
30. CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
Gyu Song G; Ho Lee Y
Immunol Invest; 2013; 42(5):409-22. PubMed ID: 23802171
[TBL] [Abstract][Full Text] [Related]
31. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice.
Mathur M; Herrmann K; Qin Y; Gulmen F; Li X; Krimins R; Weinstock J; Elliott D; Bluestone JA; Padrid P
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):498-509. PubMed ID: 10502560
[TBL] [Abstract][Full Text] [Related]
32. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population.
Ahmed S; Ihara K; Kanemitsu S; Nakashima H; Otsuka T; Tsuzaka K; Takeuchi T; Hara T
Rheumatology (Oxford); 2001 Jun; 40(6):662-7. PubMed ID: 11426024
[TBL] [Abstract][Full Text] [Related]
33. Interactions of CD80 and CD86 with CD28 and CTLA4.
Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
[TBL] [Abstract][Full Text] [Related]
34. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
35. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
36. Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.
Gunesacar R; Erken E; Bozkurt B; Ozer HT; Dinkci S; Erken EG; Ozbalkan Z
Int J Immunogenet; 2007 Feb; 34(1):45-9. PubMed ID: 17284227
[TBL] [Abstract][Full Text] [Related]
37. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
[TBL] [Abstract][Full Text] [Related]
38. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23.
Fernández-Ruiz E; Somoza C; Sánchez-Madrid F; Lanier LL
Eur J Immunol; 1995 May; 25(5):1453-6. PubMed ID: 7539761
[TBL] [Abstract][Full Text] [Related]
39. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
40. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
